• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number HLS SET
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/15/2021
Event Type  malfunction  
Event Description
It was reported that the delta pressure was increased during use.The set was replaced with no harm to the patient.Complaint id#(b)(4).
 
Manufacturer Narrative
The investigation is ongoing.Further information has been requested but has not yet been received.A follow up medwatch will be submitted when additional information becomes available.
 
Manufacturer Narrative
It was reported that the delta pressure was increased during use.The set was replaced with no harm to the patient.The patient was infected with covid-19.The affected hls module with lot#3000164491 was investigated in the getinge laboratory on 2022-04-05 with the following results.During the investigation no abnormalities were detected.Further no leakage or functional issues of the pump could be confirmed.The investigated hls module worked according to its specifications.The patient was infected with covid-19.As stated by the getinge medical affairs team and in reference to the literature [1] covid-19 diseases can be associated with intravascular coagulation activation, microcirculation disorders and increased risk of thromboembolism despite good systemic anticoagulation.The increased risk of thrombosis and coagulopathy in ecmo patients is a result of a combination of processes driven by the disease occurring in synergy with the effect of the extracorporeal circuit on the coagulation system.[1] with reference to the risk assessment hls set advanced 5.0 / hls set advanced 7.0, dms#1468452, v26 and in consultation with the manager medical affairs the following events can contribute to the reported failure: - air remains in or enters the circuit; - hemostasis; - air or blood remains in luer lock access port; - too low anticoagulation; - too low at level, effect of heparin is too limited; - protamine sulfate enters the hls set; - administration of substitution of congealable substance such as plateles; - (consumption) coagulopathy; - thrombozytopenia.The production records of the affected hls module (batch #3000164491 ) were reviewed on 2022-04-06.Following steps are performed according to the bop with a 100 % inspection: following tests are performed according to the bop as a 100 % inspection: * pressure test heat exchanger; * leak test water/gas side; * pressure test blood side; * final functional test.According to the final test results, the hls module with the serial#(b)(6) passed the tests as per specifications.There is no indication on manufacturing issues.Thus production related influences are unlikely.Based on the investigation results the reported failure "delta pressure increased" could be confirmed, but not product related malfunction.The occurrence rate was calculated for the reported failure and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿ s trending program and additional investigations or corrections will be implemented in case of adverse trending.Reference: [1] yusuff h, zochios v, brodie d."thrombosis and coagulopathy in covid-19 patients requiring extracorporeal membrane oxygenation" asaio j.2020;66(8):844-846.Doi:10.1097/mat.0000000000001208.
 
Event Description
Complaint id#(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HLS SET ADVANCED
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
Manufacturer (Section G)
JULIA KAPFENBERGER
neue rottenburger strasse 37
hechingen
Manufacturer Contact
neue rottenburger strasse 37
hechingen 
MDR Report Key13084476
MDR Text Key282805258
Report Number8010762-2021-00674
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112360
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHLS SET
Device Catalogue Number701052794
Device Lot Number3000164491 (HLS MODULE)
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 12/16/2021
Initial Date FDA Received12/24/2021
Supplement Dates Manufacturer Received04/05/2022
Supplement Dates FDA Received04/06/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-